Trial Profile
A pilot study to investigate whether the lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs Lanthanum carbonate (Primary) ; Calcium carbonate
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- 16 Sep 2015 New trial record